Health Highlights: Dec. 14, 2022

New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read more
Move to electric cars will save lives and billions in health care costs. Replacing vehicles powered by gas and diesel with electric ones will pay big dividends for Americans' health, a new study finds. Read more
Big U.S. genetics study is already helping participants. Called "All of Us," the study aims to eventually include at least 1 million people, in an effort to accelerate medical breakthroughs. Read more
Long COVID has taken the lives of more than 3,500 Americans. Research is revealing that the damage caused by a COVID infection poses a long-term risk to some who survive their bout with the coronavirus. Read more
Related Posts
Aumentan los casos de gripe en EE. UU., e instan a los adultos mayores a vacunarse
MARTES, 6 de diciembre de 2022 (HealthDay News) -- Los expertos les piden a los...
Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy
TUESDAY, July 12, 2022 (HealthDay News) -- For individuals with opioid use...
Less Than Half of U.S.-Based Clinical Trials Report Race/Ethnicity
MONDAY, April 11, 2022 (HealthDay News) -- Less than half of U.S.-based trials...
El uso reciente de marihuana se vincula con un aumento en el riesgo de ataque cardiaco de los adultos jóvenes
MARTES, 7 de septiembre de 2021 (HealthDay News) -- La marihuana se ha vinculado...
